Literature DB >> 27707790

Landscape of Genomic Alterations in Pituitary Adenomas.

Wenya Linda Bi1,2,3, Peleg Horowitz1,2,4, Noah F Greenwald1,2,3, Malak Abedalthagafi5,6,7, Pankaj K Agarwalla2,8, Wiliam J Gibson2,3, Yu Mei1, Steven E Schumacher3, Uri Ben-David3, Aaron Chevalier3, Scott Carter3,9,10,11, Grace Tiao3, Priscilla K Brastianos12,13, Azra H Ligon14, Matthew Ducar15, Laura MacConaill15, Edward R Laws1, Sandro Santagata5, Rameen Beroukhim16,3,17, Ian F Dunn18.   

Abstract

Purpose: Pituitary adenomas are the second most common primary brain tumor, yet their genetic profiles are incompletely understood.Experimental Design: We performed whole-exome sequencing of 42 pituitary macroadenomas and matched normal DNA. These adenomas included hormonally active and inactive tumors, ones with typical or atypical histology, and ones that were primary or recurrent.
Results: We identified mutations, insertions/deletions, and copy-number alterations. Nearly one-third of samples (29%) had chromosome arm-level copy-number alterations across large fractions of the genome. Despite such widespread genomic disruption, these tumors had few focal events, which is unusual among highly disrupted cancers. The other 71% of tumors formed a distinct molecular class, with somatic copy number alterations involving less than 6% of the genome. Among the highly disrupted group, 75% were functional adenomas or atypical null-cell adenomas, whereas 87% of the less-disrupted group were nonfunctional adenomas. We confirmed this association between functional subtype and disruption in a validation dataset of 87 pituitary adenomas. Analysis of previously published expression data from an additional 50 adenomas showed that arm-level alterations significantly impacted transcript levels, and that the disrupted samples were characterized by expression changes associated with poor outcome in other cancers. Arm-level losses of chromosomes 1, 2, 11, and 18 were significantly recurrent. No significantly recurrent mutations were identified, suggesting no genes are altered by exonic mutations across large fractions of pituitary macroadenomas.Conclusions: These data indicate that sporadic pituitary adenomas have distinct copy-number profiles that associate with hormonal and histologic subtypes and influence gene expression. Clin Cancer Res; 23(7); 1841-51. ©2016 AACR. ©2016 American Association for Cancer Research.

Entities:  

Mesh:

Year:  2016        PMID: 27707790      PMCID: PMC5380512          DOI: 10.1158/1078-0432.CCR-16-0790

Source DB:  PubMed          Journal:  Clin Cancer Res        ISSN: 1078-0432            Impact factor:   12.531


  59 in total

1.  Breakpointer: using local mapping artifacts to support sequence breakpoint discovery from single-end reads.

Authors:  Ruping Sun; Michael I Love; Tomasz Zemojtel; Anne-Katrin Emde; Ho-Ryun Chung; Martin Vingron; Stefan A Haas
Journal:  Bioinformatics       Date:  2012-02-01       Impact factor: 6.937

2.  NDY1/KDM2B functions as a master regulator of polycomb complexes and controls self-renewal of breast cancer stem cells.

Authors:  Filippos Kottakis; Parthena Foltopoulou; Ioannis Sanidas; Patricia Keller; Ania Wronski; Benjamin T Dake; Scott A Ezell; Zhu Shen; Stephen P Naber; Philip W Hinds; Elizabeth McNiel; Charlotte Kuperwasser; Philip N Tsichlis
Journal:  Cancer Res       Date:  2014-05-22       Impact factor: 12.701

3.  Identification of growth arrest and DNA-damage-inducible gene beta (GADD45beta) as a novel tumor suppressor in pituitary gonadotrope tumors.

Authors:  Katherine A Michaelis; Aaron J Knox; Mei Xu; Katja Kiseljak-Vassiliades; Michael G Edwards; Mark Geraci; B K Kleinschmidt-DeMasters; Kevin O Lillehei; Margaret E Wierman
Journal:  Endocrinology       Date:  2011-08-02       Impact factor: 4.736

Review 4.  Molecular genetics of multiple endocrine neoplasia types 1 and 2.

Authors:  Stephen J Marx
Journal:  Nat Rev Cancer       Date:  2005-05       Impact factor: 60.716

5.  Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles.

Authors:  Aravind Subramanian; Pablo Tamayo; Vamsi K Mootha; Sayan Mukherjee; Benjamin L Ebert; Michael A Gillette; Amanda Paulovich; Scott L Pomeroy; Todd R Golub; Eric S Lander; Jill P Mesirov
Journal:  Proc Natl Acad Sci U S A       Date:  2005-09-30       Impact factor: 11.205

6.  A signature of chromosomal instability inferred from gene expression profiles predicts clinical outcome in multiple human cancers.

Authors:  Scott L Carter; Aron C Eklund; Isaac S Kohane; Lyndsay N Harris; Zoltan Szallasi
Journal:  Nat Genet       Date:  2006-08-20       Impact factor: 38.330

7.  Delineation of two clinically and molecularly distinct subgroups of posterior fossa ependymoma.

Authors:  Hendrik Witt; Stephen C Mack; Marina Ryzhova; Sebastian Bender; Martin Sill; Ruth Isserlin; Axel Benner; Thomas Hielscher; Till Milde; Marc Remke; David T W Jones; Paul A Northcott; Livia Garzia; Kelsey C Bertrand; Andrea Wittmann; Yuan Yao; Stephen S Roberts; Luca Massimi; Tim Van Meter; William A Weiss; Nalin Gupta; Wiesia Grajkowska; Boleslaw Lach; Yoon-Jae Cho; Andreas von Deimling; Andreas E Kulozik; Olaf Witt; Gary D Bader; Cynthia E Hawkins; Uri Tabori; Abhijit Guha; James T Rutka; Peter Lichter; Andrey Korshunov; Michael D Taylor; Stefan M Pfister
Journal:  Cancer Cell       Date:  2011-08-16       Impact factor: 31.743

8.  Common genetic changes in hereditary and sporadic pituitary adenomas detected by comparative genomic hybridization.

Authors:  Svetlana D Pack; Liu-Xiu Qin; Evgenia Pak; Yun Wang; David O Ault; Poonam Mannan; Sivakumar Jaikumar; Constantine A Stratakis; Edward H Oldfield; Zhengping Zhuang; Robert J Weil
Journal:  Genes Chromosomes Cancer       Date:  2005-05       Impact factor: 5.006

9.  Gigantism and acromegaly due to Xq26 microduplications and GPR101 mutation.

Authors:  Giampaolo Trivellin; Adrian F Daly; Fabio R Faucz; Bo Yuan; Liliya Rostomyan; Darwin O Larco; Marie Helene Schernthaner-Reiter; Eva Szarek; Letícia F Leal; Jean-Hubert Caberg; Emilie Castermans; Chiara Villa; Aggeliki Dimopoulos; Prashant Chittiboina; Paraskevi Xekouki; Nalini Shah; Daniel Metzger; Philippe A Lysy; Emanuele Ferrante; Natalia Strebkova; Nadia Mazerkina; Maria Chiara Zatelli; Maya Lodish; Anelia Horvath; Rodrigo Bertollo de Alexandre; Allison D Manning; Isaac Levy; Margaret F Keil; Maria de la Luz Sierra; Leonor Palmeira; Wouter Coppieters; Michel Georges; Luciana A Naves; Mauricette Jamar; Vincent Bours; T John Wu; Catherine S Choong; Jerome Bertherat; Philippe Chanson; Peter Kamenický; William E Farrell; Anne Barlier; Martha Quezado; Ivana Bjelobaba; Stanko S Stojilkovic; Jurgen Wess; Stefano Costanzi; Pengfei Liu; James R Lupski; Albert Beckers; Constantine A Stratakis
Journal:  N Engl J Med       Date:  2014-12-03       Impact factor: 91.245

10.  The genomic complexity of primary human prostate cancer.

Authors:  Michael F Berger; Michael S Lawrence; Francesca Demichelis; Yotam Drier; Kristian Cibulskis; Andrey Y Sivachenko; Andrea Sboner; Raquel Esgueva; Dorothee Pflueger; Carrie Sougnez; Robert Onofrio; Scott L Carter; Kyung Park; Lukas Habegger; Lauren Ambrogio; Timothy Fennell; Melissa Parkin; Gordon Saksena; Douglas Voet; Alex H Ramos; Trevor J Pugh; Jane Wilkinson; Sheila Fisher; Wendy Winckler; Scott Mahan; Kristin Ardlie; Jennifer Baldwin; Jonathan W Simons; Naoki Kitabayashi; Theresa Y MacDonald; Philip W Kantoff; Lynda Chin; Stacey B Gabriel; Mark B Gerstein; Todd R Golub; Matthew Meyerson; Ashutosh Tewari; Eric S Lander; Gad Getz; Mark A Rubin; Levi A Garraway
Journal:  Nature       Date:  2011-02-10       Impact factor: 49.962

View more
  35 in total

1.  The Genomic Landscape of Sporadic Prolactinomas.

Authors:  Sunita M C De Sousa; Paul P S Wang; Stephen Santoreneos; Angeline Shen; Christopher J Yates; Milena Babic; Leila Eshraghi; Jinghua Feng; Barbara Koszyca; Samuel Roberts-Thomson; Andreas W Schreiber; David J Torpy; Hamish S Scott
Journal:  Endocr Pathol       Date:  2019-12       Impact factor: 3.943

2.  Clinical Identification of Oncogenic Drivers and Copy-Number Alterations in Pituitary Tumors.

Authors:  Wenya Linda Bi; Noah F Greenwald; Shakti H Ramkissoon; Malak Abedalthagafi; Shannon M Coy; Keith L Ligon; Yu Mei; Laura MacConaill; Matt Ducar; Le Min; Sandro Santagata; Ursula B Kaiser; Rameen Beroukhim; Edward R Laws; Ian F Dunn
Journal:  Endocrinology       Date:  2017-07-01       Impact factor: 4.736

Review 3.  Genomics and Epigenomics of Pituitary Tumors: What Do Pathologists Need to Know?

Authors:  Sylvia L Asa; Ozgur Mete; Shereen Ezzat
Journal:  Endocr Pathol       Date:  2021-01-12       Impact factor: 3.943

4.  P21Waf1/Cip1 and p27Kip1 are correlated with the development and invasion of prolactinoma.

Authors:  Wei Dong; Jianhua Li; Qian Liu; Chunhui Liu; Chuzhong Li; Guidong Song; Haibo Zhu; Hua Gao; Yazhuo Zhang
Journal:  J Neurooncol       Date:  2017-12-11       Impact factor: 4.130

Review 5.  Prognostic factors of regrowth in nonfunctioning pituitary tumors.

Authors:  Gerald Raverot; Alexandre Vasiljevic; Emmanuel Jouanneau
Journal:  Pituitary       Date:  2018-04       Impact factor: 4.107

Review 6.  Genomic Alterations in Sporadic Pituitary Tumors.

Authors:  Wenya Linda Bi; Alexandra Giantini Larsen; Ian F Dunn
Journal:  Curr Neurol Neurosci Rep       Date:  2018-02-02       Impact factor: 5.081

7.  Oncogene-induced DNA damage: cyclic AMP steps into the ring.

Authors:  James A Fagin; John H Petrini
Journal:  J Clin Invest       Date:  2020-11-02       Impact factor: 14.808

8.  DNA damage and growth hormone hypersecretion in pituitary somatotroph adenomas.

Authors:  Anat Ben-Shlomo; Nan Deng; Evelyn Ding; Masaaki Yamamoto; Adam Mamelak; Vera Chesnokova; Artak Labadzhyan; Shlomo Melmed
Journal:  J Clin Invest       Date:  2020-11-02       Impact factor: 14.808

Review 9.  Epigenetic regulation in the tumorigenesis of MEN1-associated endocrine cell types.

Authors:  Sucharitha Iyer; Sunita K Agarwal
Journal:  J Mol Endocrinol       Date:  2018-04-03       Impact factor: 5.098

10.  DNA methylation-based signatures classify sporadic pituitary tumors according to clinicopathological features.

Authors:  Maritza S Mosella; Thais S Sabedot; Tiago C Silva; Tathiane M Malta; Felipe Segato Dezem; Karam P Asmaro; Michael Wells; Abir Mukherjee; Laila M Poisson; James Snyder; Ana C deCarvalho; Tobias Walbert; Todd Aho; Steven Kalkanis; Paula C Elias; Sonir R Antonini; Jack Rock; Houtan Noushmehr; Margaret Castro; Ana Valeria Castro
Journal:  Neuro Oncol       Date:  2021-08-02       Impact factor: 12.300

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.